What is Upstream Biotechnology worth?
$1.4Mlast known valuation
Upstream Biotechnology last raised $625K in its Seed Round (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Upstream Biotechnology
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Seed Round | $625K | ▮ | ▮ |
How Upstream Biotechnology's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Upstream Biotechnology, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Upstream Biotechnology worth?
- Upstream Biotechnology's implied valuation is $1.4M, based on the PA Mark composite price of about $7 per share as of Sep 2026.
- How much has Upstream Biotechnology raised?
- Upstream Biotechnology has raised $830K in total funding across 1 recorded rounds.
- When did Upstream Biotechnology last raise?
- Upstream Biotechnology last raised in Aug 2025 (Seed Round), raising $625K.